81 related articles for article (PubMed ID: 2147362)
1. Maternal serum hCG and SP1 in pregnancies with fetal aneuploidy.
Bartels I; Thiele M; Bogart MH
Am J Med Genet; 1990 Oct; 37(2):261-4. PubMed ID: 2147362
[TBL] [Abstract][Full Text] [Related]
2. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
[TBL] [Abstract][Full Text] [Related]
4. Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay.
Talbot JA; Spencer K; Abushoufa RA
Prenat Diagn; 2003 Jan; 23(1):1-5. PubMed ID: 12533803
[TBL] [Abstract][Full Text] [Related]
5. First-trimester maternal serum PAPP-A, SP1 and M-CSF levels in normal and trisomic twin pregnancies.
Bersinger NA; Noble P; Nicolaides KH
Prenat Diagn; 2003 Feb; 23(2):157-62. PubMed ID: 12575025
[TBL] [Abstract][Full Text] [Related]
6. Triploidy identified through second-trimester serum screening.
Huang T; Alberman E; Wald N; Summers AM
Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
[TBL] [Abstract][Full Text] [Related]
7. Abnormal maternal serum levels of human chorionic gonadotropin free subunits in trisomy 18.
Ozturk M; Milunsky A; Brambati B; Sachs ES; Miller SL; Wands JR
Am J Med Genet; 1990 Aug; 36(4):480-3. PubMed ID: 2389806
[TBL] [Abstract][Full Text] [Related]
8. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A
Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
[TBL] [Abstract][Full Text] [Related]
9. [Fetoplacental antigens in pregnancies with fetal chromosomal aberrations].
Fialová L; Malbohan I; Mikulíková L; Hájek Z
Sb Lek; 1993; 94(2):179-83. PubMed ID: 7527584
[TBL] [Abstract][Full Text] [Related]
10. Maternal serum screening of fetal chromosomal abnormalities by AFP, UE3, hCG and free-beta hCG. Prospective and retrospective results.
Valerio D; Aiello R; Altieri V; Fagnoni P
Minerva Ginecol; 1996 May; 48(5):169-73. PubMed ID: 8783867
[TBL] [Abstract][Full Text] [Related]
11. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death.
Spencer K; Cowans NJ; Avgidou K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Oct; 28(5):637-43. PubMed ID: 16952214
[TBL] [Abstract][Full Text] [Related]
12. Variation in the levels of pregnancy-specific beta-1-glycoprotein in maternal serum from chromosomally abnormal pregnancies.
Graham GW; Crossley JA; Aitken DA; Connor JM
Prenat Diagn; 1992 Jun; 12(6):505-12. PubMed ID: 1387478
[TBL] [Abstract][Full Text] [Related]
13. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities.
Bogart MH; Pandian MR; Jones OW
Prenat Diagn; 1987 Nov; 7(9):623-30. PubMed ID: 2447576
[TBL] [Abstract][Full Text] [Related]
14. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
Benn PA
Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy specific beta 1-glycoprotein and human chorionic gonadotrophin levels n amniotic fluid and maternal serum in the first half of pregnancy.
Heikinheimo M; Seppälä M; Brock DJ
Oncodev Biol Med; 1980 Aug; 1(1):71-6. PubMed ID: 6974343
[TBL] [Abstract][Full Text] [Related]
16. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics.
Kagan KO; Wright D; Spencer K; Molina FS; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 May; 31(5):493-502. PubMed ID: 18432600
[TBL] [Abstract][Full Text] [Related]
17. Urinary screening tests for fetal Down syndrome: II. Hyperglycosylated hCG.
Cole LA; Shahabi S; Oz UA; Rinne KM; Omrani A; Bahado-Singh RO; Mahoney MJ
Prenat Diagn; 1999 Apr; 19(4):351-9. PubMed ID: 10327141
[TBL] [Abstract][Full Text] [Related]
18. First-trimester maternal serum human thyroid-stimulating hormone in chromosomally normal and Down syndrome pregnancies.
Weinans MJ; Pratt JJ; de Wolf BT; Mantingh A
Prenat Diagn; 2001 Sep; 21(9):723-5. PubMed ID: 11559906
[TBL] [Abstract][Full Text] [Related]
19. Second-trimester levels of pregnancy-associated plasma protein-A and free beta-hCG in pregnancies with trisomy 13.
Spencer K; Crossley JA; Aitken DA; Nicolaides KH
Prenat Diagn; 2005 May; 25(5):358-61. PubMed ID: 15906423
[TBL] [Abstract][Full Text] [Related]
20. Maternal serum levels of placental proteins after in vitro fertilisation and their implications for prenatal screening.
Bersinger NA; Wunder D; Vanderlick F; Chanson A; Pescia G; Janecek P; Boillat E; Birkhäuser MH
Prenat Diagn; 2004 Jun; 24(6):471-7. PubMed ID: 15229849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
